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Objective 
In 2010, the Centers for Disease Control 
and Prevention updated the Guidelines 
for the Prevention of Perinatal Group B 
Streptococcal (GBS) Disease. Previous 
studies of adherence to GBS guidelines 
have focused on the treatment of 
carriers of GBS. Our objective was to 
determine whether there was any 
difference in adherence to the 
guidelines for screening and treatment 
of women who delivered at our 
institution between the beginning of 
2011 and the end of 2011 as the revised 
guidelines were published in November 
2010. Our secondary outcome was to 
determine whether any differences in 
adherence occurred between prenatal 
provider types (OB/Gyn, Certified Nurse 
Midwives, and Family Practice). 
Study Design 
A retrospective cohort study in which 
demographic and clinical information 
were extracted from patients that 
delivered in 2011 (IRB# 201208773). 
We extracted data for the first 150 
deliveries (Group 1) and the last 150 
deliveries of 2011 (Group 2). Data was 
extracted from the electronic health 
record (Epic) and entered into an 
electronic database (REDCap). Chi-
square analysis was performed for 
statistical comparisons. 
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Results 
Including all providers, compliance for 
Group 1 was 95.5% and for Group 2 
was 90.4% (P=0.021). No statistical 
difference was found between provider 
types in Group 1 (P=0.341). However, in 
Group 2, there was a significant 
difference in adherence between 
provider types (P=0.03). In Group 2, the 
OB/Gyn obstetric providers had the 
lowest adherence at 89%. 
Conclusions 
Following a strict interpretation of the 
2010 CDC guidelines, our institution had 
a very high rate of compliance for 
screening and treating pregnant women 
for GBS. This is critically important due 
to increasing antibiotic resistance in 
GBS. Adherence to the revised 
guidelines was higher at the beginning 
of 2011, immediately following the 
publication of the revised guidelines. 
These results suggest a need to 
periodically re-educate obstetric 
providers of the guidelines 
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